SCHEMBL7975646

SCHEMBL7975646

C=C1C(Cl)=C(Nc2ccc(S(=O)(=O)Nc3cc(OC)nc(OC)n3)cc2)C(=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.56
KMT2A Q03164 6/20 0.55
ALDH1A1 P00352 3/20 0.55
HTT P42858 2/20 0.55
P2RY1 P47900 1/20 0.54
MEN1 O00255 3/20 0.54
KDM4E B2RXH2 1/20 0.54
MAPT P10636 1/20 0.54
GPR55 Q9Y2T6 1/20 0.54
LMNA P02545 1/20 0.54
CYP3A4 P08684 1/20 0.54
HTR6 P50406 1/20 0.54
PSMB1 P20618 2/20 0.53
PSMB5 P28074 2/20 0.53
PSMB2 P49721 2/20 0.53
ALOX12 P18054 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2240548 0.92 AKT1 (0.64) AKT1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL2239637 0.86 AKT1 (0.67) AKT1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL21753106 0.76 ALDH1A1 (0.76) AKT1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL328335 0.75 AKT1 (1.00) AKT1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL7824834 0.73 ALDH1A1 (0.78) AKT1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL4556022 0.72 P2RY1 (0.83) AKT1SMN1; SMN2KMT2AALDH1A1HTT
Sulfadimethoxine SCHEMBL29363944 0.72 LMNA (1.00) AKT1SMN1; SMN2KMT2AALDH1A1HTT
Sulfadimethoxine SCHEMBL93845 0.72 LMNA (1.00) AKT1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL328334 0.71 ALOX12 (0.81) AKT1SMN1; SMN2KMT2AALDH1A1HTT
Sulfadimethoxine SCHEMBL2430279 0.71 LMNA (0.97) AKT1SMN1; SMN2KMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005534-A2 PROTEASOME INHIBITORS FOR SELECTIVELY INDUCING APOPTOSIS IN CANCER CELLS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2010-01-14 WO disclosed